FDA Unveils Plan To Boost Transparency To Industry
This article was originally published in The Rose Sheet
Executive Summary
FDA has identified 19 steps to improve its communications with drug and medical device manufacturers, promising quicker responses to industry questions.
You may also be interested in...
FDA Should Broaden Consumer Access To Compliance Info – Task Force
FDA’s transparency task force proposes a multi-pronged approach to make the agency’s compliance and enforcement data more accessible and user-friendly online.
FDA Should Broaden Consumer Access To Compliance Info – Task Force
FDA’s transparency task force proposes a multi-pronged approach to make the agency’s compliance and enforcement data more accessible and user-friendly online.
Taylor Is Sharfstein's Temporary Replacement As FDA's Second-In-Command
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Joshua Sharfstein's departure.